-
ALS Trial Results of Tirasemtiv Show Potential of Similar Therapies
Phase 3 trial results of now-discontinued tirasemtiv show that other fast skeletal muscle troponin activators now in development may hold potential for treating ALS. Click here to read the full story.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.